with the latter being required for the aversive effects of systemic lithium chloride (LiCl) in mice [65]. In the context of GLP-1R agonists, systemic exendin-4 robustly activates CGRP-expressing lPBN neurons, and its chronic weight-lowering effects are attenuated...